Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Measuring participation as defined by the World Health Organization in the International Classification of Functioning, Disability and Health. Psychometric properties of the Ghent Participation Scale.
An inhibitor of chondroitin sulfate proteoglycan synthesis promotes central nervous system remyelination.
Compromised axon initial segment integrity in EAE is preceded by microglial reactivity and contact.
Effects of Delayed-Release Dimethyl Fumarate (DMF) on Health-Related Quality of Life in Patients With Relapsing-Remitting Multiple Sclerosis: An Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies.
CLIC1 regulates dendritic cell antigen processing and presentation by modulating phagosome acidification and proteolysis.
Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain.
Fingolimod modulates multiple neuroinflammatory markers in a mouse model of Alzheimer's disease.
Rare onset symptoms in multiple sclerosis.
CNS vasculitis in a patient with MS on daclizumab monotherapy.
Hyperforin-loaded gold nanoparticle alleviates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells and upregulating regulatory T cells.
Leflunomide: mode of action in the treatment of rheumatoid arthritis.
AB Science confirms the filing for the Marketing Authorization Application to the European Medicines Agency of masitinib in the treatment of pancreatic cancer
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
Multiple Sclerosis and Catastrophic Health Expenditure in Iran.
Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
Self-assembling nanocomplexes by combining ferumoxytol, heparin and protamine for cell tracking by magnetic resonance imaging.
Mechanism of action for leflunomide in rheumatoid arthritis.
Ampyra (Fampyra)
Arginase-1 is expressed exclusively by infiltrating myeloid cells in CNS injury and disease.
Cervical cord and ventricle affection in neuromyelitis optica.
Central fatigue in multiple sclerosis: a review of the literature.
Regulation of B cell function by the immunosuppressive agent leflunomide.
Pathogenic implications of iron accumulation in multiple sclerosis.
Preclinical studies of sex differences: a clinical perspective.
Postpartum relapses increase the risk of disability progression in multiple sclerosis: the role of disease modifying drugs.
Pages
« first
‹ previous
…
78
79
80
81
82
83
84
85
86
…
next ›
last »